Design, Synthesis and In Vitro Evaluation of Piperazine Incorporated Novel Anticancer Agents

Simple item page
dc.contributor.authorJadhav, Hemant R.
dc.date.accessioned2023-11-30T10:32:33Z
dc.date.available2023-11-30T10:32:33Z
dc.date.issued2018
dc.description.abstractNovel 4-(3-(4-ethylpiperazin-1-yl)propoxy)-N-phenylbenzamide derivatives (C-1 to C-10) and (4-(3-(4-ethylpiperazin-1-yl)propoxy)phenyl)(4-(2-methoxyphenyl)piperazin-1- yl)ethanone derivatives (C-11 to C-16) were designed and synthesized by pharmacophore approach.en_US
dc.identifier.urihttps://benthamscience.com/article/87338
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13288
dc.language.isoenen_US
dc.publisherBentham Scienceen_US
dc.subjectPharmacyen_US
dc.subjectCarcinomaen_US
dc.subjectCytotoxocityen_US
dc.subjectEpidermal growth factor receptor inhibitorsen_US
dc.subjectEthyl piperazineen_US
dc.subjectCancer lineen_US
dc.titleDesign, Synthesis and In Vitro Evaluation of Piperazine Incorporated Novel Anticancer Agentsen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Department of Pharmacy